HDAC6 promote HCCLM3 cell migration and invasion by regulating TGF-β1pathway
Abstract
Histone deacetylase 6 (HDAC6) have been demonstrated to play critical roles in the progression of tumor migration and invasion in recent years.However, little research has been done on hepatocellular carcinoma (HCC). This study investigated the role of HDAC6 in the migration and invasion of HCCLM3 cells and its potential mechanism. Western blot and immunohistochemistry were used to detect the expression of HDAC6 in normal hepatic cell line LO2 and HCC cell line HCCLM3. Transforming growth factor 1 (TGF-{beta}1) was proved as a direct target of HDAC6 by Western blot and qRT-PCR.The changes of migration and invasion ability of HCCLM3 cells were confirmed by wound healing and Transwell assays.Morphological changes of HCCLM3 cells were observed by microscope.Our study proved that drownregulated HDAC6 supress HCCLM3 cells metastasis and invasion. Meanwhile, our study verified that HDAC6 regulate EMT by targeting TGF-{beta}1.In conclusion, HDAC6 inhibits the EMT of HCCLM3 cells and further inhibits the migration and invasion of HCCLM3 cells by downregulating the expression of TGF-{beta}1.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- NOVEL NUCLEAR ROLE OF HDAC6 IN PROGNOSIS AND THERAPEUTIC TARGET FOR COLORECTAL CANCER
D. J. Garcia-Dominguez, L. Hontecillas-Prieto, … N. Hajji·bioRxiv·Nov 2, 2020
- B7-H3 Modulates Cell Adhesion and Immune Evasion to Promote Tumor Progression and Natural Killer Cell Resistance in Hepatocellular Carcinoma
San Ha Han, Yoo Jin Cheon, … Chun Jeih Ryu·bioRxiv·Mar 31, 2026
- Epigenetic remodeling via HDAC6 inhibition amplifies anti-tumoral immune responses in myeloid leukemia cells
Julian Schliehe‐Diecks, Jia‐Wey Tu, … Sanil Bhatia·Cell Death and DiseasePeer-reviewed·Mar 7, 2026
- BACH1 promotes hepatocellular carcinoma progression by targeting PDP1 towards the PI3K-AKT-mTOR signaling activation
Qiqi Bu, Xiaojing Qi, … Yiguo Zhang·Bioorganic ChemistryPeer-reviewed·Oct 31, 2025
- KDM6B interacts with nucleo-adhesome components CSRP2 and TGFB1I1 to regulate EMT
Jules Durand, Montagnon Frederic, … Paul Peixoto·bioRxiv·Aug 25, 2026
- Ligand-independent c-Met activation by HHLA2 drives hepatocellular carcinoma and predicts c-MET inhibitor efficacy
Xubo Huang, Runya Fang, … Yongjie Wei·Journal of Experimental & Clinical Cancer ResearchPeer-reviewed·May 20, 2025